Literature DB >> 27326337

N1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like Properties.

Paweł Zajdel1, Krzysztof Marciniec2, Grzegorz Satała3, Vittorio Canale1, Tomasz Kos3, Anna Partyka1, Magdalena Jastrzębska-Więsek1, Anna Wesołowska1, Agnieszka Basińska-Ziobroń3, Jacek Wójcikowski3, Władysława A Daniel3, Andrzej J Bojarski3, Piotr Popik4.   

Abstract

A series of N1-azinylsulfonyl-3-(1,2,3,6,tetrahyrdopyridin-4-yl)-1H-indole derivatives was designed to obtain highly potent 5-HT6 receptor ligands. The study allowed for the identification of 25 (4-{[5-methoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-1-yl]sulfonyl}isoquinoline), a potent and selective 5-HT6 receptor antagonist. The selected compound, was evaluated in vivo in a novel object recognition (NOR) and forced swim (FST) tests in rats, demonstrating distinct pro-cognitive and antidepressant-like properties (MED = 1 mg/kg and 0.1 mg/kg, i.p., respectively). Compound SB-742457, used as comparator, reversed memory deficits in NOR task in similar doses, while in FST it was active in 10-30-fold higher dose (3 mg/kg). In contrast to SB-742457, which was active in Vogel test (MED = 3 mg/kg), compound 25 displayed no anxiolytic activity.

Entities:  

Keywords:  5-HT6 receptor antagonist; Alzheimer’s disease; Isoquinoline/quinoline sulfonamides; Vogel test; cognitive decline; forced swim test; novel object recognition task

Year:  2016        PMID: 27326337      PMCID: PMC4904269          DOI: 10.1021/acsmedchemlett.6b00056

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  24 in total

1.  Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents: the synthesis and pharmacological evaluation.

Authors:  Paweł Zajdel; Krzysztof Marciniec; Andrzej Maślankiewicz; Grzegorz Satała; Beata Duszyńska; Andrzej J Bojarski; Anna Partyka; Magdalena Jastrzębska-Więsek; Dagmara Wróbel; Anna Wesołowska; Maciej Pawłowski
Journal:  Bioorg Med Chem       Date:  2012-01-04       Impact factor: 3.641

2.  Behavioural despair in rats: a new model sensitive to antidepressant treatments.

Authors:  R D Porsolt; G Anton; N Blavet; M Jalfre
Journal:  Eur J Pharmacol       Date:  1978-02-15       Impact factor: 4.432

Review 3.  5-HT(6) receptor and cognition.

Authors:  Xabier Codony; Jose Miguel Vela; Maria Javier Ramírez
Journal:  Curr Opin Pharmacol       Date:  2011-02-15       Impact factor: 5.547

4.  A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data.

Authors:  A Ennaceur; J Delacour
Journal:  Behav Brain Res       Date:  1988-11-01       Impact factor: 3.332

5.  Structure-activity relationship studies of CNS agents. Part 9: 5-HT1A and 5-HT2 receptor affinity of some 2- and 3-substituted 1,2,3,4-tetrahydro-beta-carbolines.

Authors:  A J Bojarski; M T Cegła; S Charakchieva-Minol; M J Mokrosz; M Maćkowiak; S Misztal; J L Mokrosz
Journal:  Pharmazie       Date:  1993-04       Impact factor: 1.267

6.  Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat.

Authors:  B Marcos; T T Chuang; F J Gil-Bea; M J Ramirez
Journal:  Br J Pharmacol       Date:  2008-07-14       Impact factor: 8.739

7.  Cdk5 induces constitutive activation of 5-HT6 receptors to promote neurite growth.

Authors:  Fanny Duhr; Paul Déléris; Fabrice Raynaud; Martial Séveno; Séverine Morisset-Lopez; Clotilde Mannoury la Cour; Mark J Millan; Joël Bockaert; Philippe Marin; Séverine Chaumont-Dubel
Journal:  Nat Chem Biol       Date:  2014-06-01       Impact factor: 15.040

Review 8.  5-HT(6) receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffolds.

Authors:  Alexandre V Ivachtchenko; Yan A Ivanenkov; Andrey V Skorenko
Journal:  Expert Opin Ther Pat       Date:  2012-09-07       Impact factor: 6.674

9.  Procognitive 5-HT6 antagonists in the rat forced swimming test: potential therapeutic utility in mood disorders associated with Alzheimer's disease.

Authors:  Kazufumi Hirano; Thomas M Piers; Kirsten L Searle; Neil D Miller; A Richard Rutter; Paul F Chapman
Journal:  Life Sci       Date:  2009-02-07       Impact factor: 5.037

10.  1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats.

Authors:  Piotr Popik; Malgorzata Holuj; Agnieszka Nikiforuk; Tomasz Kos; Ramon Trullas; Phil Skolnick
Journal:  Psychopharmacology (Berl)       Date:  2014-09-27       Impact factor: 4.530

View more
  10 in total

Review 1.  Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status.

Authors:  Hilda Ferrero; Maite Solas; Paul T Francis; Maria J Ramirez
Journal:  CNS Drugs       Date:  2017-01       Impact factor: 5.749

2.  Are the Hydantoin-1,3,5-triazine 5-HT6R Ligands a Hope to a Find New Procognitive and Anti-Obesity Drug? Considerations Based on Primary In Vivo Assays and ADME-Tox Profile In Vitro.

Authors:  Annamaria Lubelska; Gniewomir Latacz; Magdalena Jastrzębska-Więsek; Magdalena Kotańska; Rafał Kurczab; Anna Partyka; Małgorzata Anna Marć; Daria Wilczyńska; Agata Doroz-Płonka; Dorota Łażewska; Anna Wesołowska; Katarzyna Kieć-Kononowicz; Jadwiga Handzlik
Journal:  Molecules       Date:  2019-12-06       Impact factor: 4.411

3.  Sustainable Synthesis of a Potent and Selective 5-HT7 Receptor Antagonist Using a Mechanochemical Approach.

Authors:  Vittorio Canale; Valeria Frisi; Xavier Bantreil; Frédéric Lamaty; Paweł Zajdel
Journal:  J Org Chem       Date:  2020-08-11       Impact factor: 4.354

4.  Constitutive Activity of Serotonin Receptor 6 Regulates Human Cerebral Organoids Formation and Depression-like Behaviors.

Authors:  Qinying Wang; Xiaoxu Dong; Tingting Hu; Chao Qu; Jing Lu; Yue Zhou; Jinsong Li; Gang Pei
Journal:  Stem Cell Reports       Date:  2020-12-23       Impact factor: 7.765

5.  The Faster-Onset Antidepressant Effects of Hypidone Hydrochloride (YL-0919) in Monkeys Subjected to Chronic Unpredictable Stress.

Authors:  Yong-Yu Yin; Chao-Yang Tian; Xin-Xin Fang; Chao Shang; Li-Ming Zhang; Qiang Xu; Yun-Feng Li
Journal:  Front Pharmacol       Date:  2020-11-26       Impact factor: 5.810

6.  2-Phenyl-1H-pyrrole-3-carboxamide as a New Scaffold for Developing 5-HT6 Receptor Inverse Agonists with Cognition-Enhancing Activity.

Authors:  Marcin Drop; Vittorio Canale; Séverine Chaumont-Dubel; Rafał Kurczab; Grzegorz Satała; Xavier Bantreil; Maria Walczak; Paulina Koczurkiewicz-Adamczyk; Gniewomir Latacz; Anna Gwizdak; Martyna Krawczyk; Joanna Gołębiowska; Katarzyna Grychowska; Andrzej J Bojarski; Agnieszka Nikiforuk; Gilles Subra; Jean Martinez; Maciej Pawłowski; Piotr Popik; Philippe Marin; Frédéric Lamaty; Paweł Zajdel
Journal:  ACS Chem Neurosci       Date:  2021-03-11       Impact factor: 4.418

7.  Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties.

Authors:  Paweł Zajdel; Katarzyna Grychowska; Szczepan Mogilski; Rafał Kurczab; Grzegorz Satała; Ryszard Bugno; Tomasz Kos; Joanna Gołębiowska; Natalia Malikowska-Racia; Agnieszka Nikiforuk; Séverine Chaumont-Dubel; Xavier Bantreil; Maciej Pawłowski; Jean Martinez; Gilles Subra; Frédéric Lamaty; Philippe Marin; Andrzej J Bojarski; Piotr Popik
Journal:  J Med Chem       Date:  2021-09-01       Impact factor: 7.446

Review 8.  TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review.

Authors:  Ye Zixin; Chen Lulu; Zeng Xiangchang; Fang Qing; Zheng Binjie; Luo Chunyang; Rao Tai; Ouyang Dongsheng
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

Review 9.  Drug Discovery and Development of Novel Therapeutics for Inhibiting TMAO in Models of Atherosclerosis and Diabetes.

Authors:  Ian Steinke; Nila Ghanei; Manoj Govindarajulu; Sieun Yoo; Juming Zhong; Rajesh H Amin
Journal:  Front Physiol       Date:  2020-10-29       Impact factor: 4.566

10.  Effect of 5-HT6 Receptor Ligands Combined with Haloperidol or Risperidone on Antidepressant-/Anxiolytic-Like Behavior and BDNF Regulation in Hippocampus and Prefrontal Cortex of Rats.

Authors:  Anna Wesołowska; Joanna Rychtyk; Joanna Gdula-Argasińska; Katarzyna Górecka; Natalia Wilczyńska-Zawal; Magdalena Jastrzębska-Więsek; Anna Partyka
Journal:  Neuropsychiatr Dis Treat       Date:  2021-06-25       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.